BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3530116)

  • 1. Evaluation of platinol analogs using the M5076 murine sarcoma.
    Rose WC
    Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.
    Müller LJ; Moorer-van Delft CM; Roubos EW; Vermorken JB; Boer HH
    Cancer Res; 1992 Feb; 52(4):963-73. PubMed ID: 1737358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
    Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK
    Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical antitumor and toxicologic profile of carboplatin.
    Rose WC; Schurig JE
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-19. PubMed ID: 3910215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical antitumor activity of orally administered platinum (IV) complexes.
    Rose WC; Crosswell AR; Schurig JE; Casazza AM
    Cancer Chemother Pharmacol; 1993; 32(3):197-203. PubMed ID: 8500224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay].
    Terashima M; Ikeda K; Kawamura S; Takagane A; Maesawa C; Sudoh T; Okamoto K; Ishida K; Satoh M; Saito K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):269-73. PubMed ID: 2405778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
    Hashimura T; Okada K; Yoshida O
    Gan To Kagaku Ryoho; 1985 May; 12(5):1137-42. PubMed ID: 3888118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Kyriazis AA; Yagoda A; Fogh J
    Cancer Res; 1985 Sep; 45(9):4354-9. PubMed ID: 3896479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second-generation cisplatin analogs].
    Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1043-50. PubMed ID: 3551846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.
    Saegusa Y; Eriguchi M; Kidani Y; Matsuzawa A; Takeda Y
    Anticancer Res; 2001; 21(1A):245-52. PubMed ID: 11299742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
    Presnov MA; Konovalova AL
    Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer.
    Rho YS; Lee KT; Jung JC; Yoon C; An Z; Hoffman RM; Chang SG
    Anticancer Res; 1999; 19(1A):157-61. PubMed ID: 10226537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic treatment of xenograft Spirocerca lupi-associated sarcoma in a murine model.
    Stettner N; Ranen E; Dank G; Lavy E; Brenner O; Harmelin A
    Comp Med; 2007 Jun; 57(3):267-71. PubMed ID: 17605341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.